End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,210 KRW | +1.39% | -5.20% | +8.85% |
Business Summary
Number of employees: 308
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals Manufacturing
74.7
%
| 99,593 | 75.5 % | 105,549 | 74.7 % | +5.98% |
Pharmaceutical Wholesaler
15.7
%
| 23,225 | 17.6 % | 22,144 | 15.7 % | -4.65% |
Cosmetics and Medical Device Manufacturing
4.9
%
| 5,034 | 3.8 % | 6,891 | 4.9 % | +36.87% |
Pharmaceutical Raw Material Manufacturing
4.7
%
| 3,958 | 3.0 % | 6,694 | 4.7 % | +69.14% |
Medical Information System
0.1
%
| 102 | 0.1 % | 81 | 0.1 % | -20.03% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
91.0
%
| 117,086 | 88.8 % | 128,628 | 91.0 % | +9.86% |
Germany
4.9
%
| 5,034 | 3.8 % | 6,891 | 4.9 % | +36.87% |
Myanmar/Cambodia
1.5
%
| 2,105 | 1.6 % | 2,117 | 1.5 % | +0.59% |
Vietnam
1.0
%
| 640 | 0.5 % | 1,406 | 1.0 % | +119.61% |
Other
0.9
%
| 2,268 | 1.7 % | 1,226 | 0.9 % | -45.95% |
Ecuador/Bolivia
0.8
%
| 1,162 | 0.9 % | 1,085 | 0.8 % | -6.58% |
China
0.0
%
| 3,617 | 2.7 % | 6 | 0.0 % | -99.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Byung-Tae Noh
CEO | Chief Executive Officer | 62 | 15/85/15 |
Eun-Seok Kim
CEO | Chief Executive Officer | 48 | 01/08/01 |
Jae-Seong Na
DFI | Director of Finance/CFO | 55 | 01/93/01 |
Jae-Gwon Yang
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/08/01 |
Sang-Tae Lee
BRD | Director/Board Member | 59 | 01/89/01 |
Shin-Won Bang
SAM | Sales & Marketing | 54 | - |
Tae-Hoon Kim
HRO | Human Resources Officer | 49 | 01/18/01 |
Boon-Yeon Ahn
PRN | Corporate Officer/Principal | 59 | 01/92/01 |
Nam-Soo Han
PRN | Corporate Officer/Principal | 68 | - |
Shin-Bae Ji
PRN | Corporate Officer/Principal | 60 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eun-Seok Kim
CEO | Chief Executive Officer | 48 | 01/08/01 |
Byung-Tae Noh
CEO | Chief Executive Officer | 62 | 15/85/15 |
Sang-Tae Lee
BRD | Director/Board Member | 59 | 01/89/01 |
Jae-Gwon Yang
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/08/01 |
Jong-Il Kim
BRD | Director/Board Member | 62 | 24/17/24 |
Hye-Seon Jeong
BRD | Director/Board Member | 63 | 01/18/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,616,650 | 12,091,717 ( 64.95 %) | 1,100,000 ( 5.909 %) | 64.95 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,100,000 | 5.91% | 8,810,505 $ |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+8.85% | 129M | |
+9.85% | 72.5B | |
+13.69% | 9.11B | |
-12.85% | 5.07B | |
+60.16% | 5.01B | |
+1.60% | 3.85B | |
-19.20% | 2.46B | |
+18.65% | 2.44B | |
+24.62% | 2.27B | |
-27.46% | 2.26B |
- Stock Market
- Equities
- A067080 Stock
- Company DAE HWA Pharmaceutical Co., Ltd.